Valeo Financial Advisors, LLC Adaptive Biotechnologies Corp Transaction History

Valeo Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$32.22 - $44.59 $6,830 - $9,453	-212 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$37.26 - $67.74 $335 - $609	-9 Reduced 4.07%	212 $9,000
Q1 2020 Apr 13, 2020	BUY	$16.96 - $34.16 $2,764 - $5,568	163 Added 281.03%	221 $6,000
Q3 2019 Oct 15, 2019	BUY	$30.31 - $53.51 $1,757 - $3,103	58 New	58 $2,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $857M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.